Non-pharmacological strategies for blood conservation in cardiac surgery

Canadian Journal of Anesthesia

Volumn 48, Issue 4 SUPPL., 2001, Pages

  Ruel, Marc A ^a   Rubens, Fraser D ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TISSUE ADHESIVE;

ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING DISORDER; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; COST; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; ELECTIVE SURGERY; HEALTH HAZARD; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMODILUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; META ANALYSIS; PLASMAPHERESIS; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVASCULARIZATION; SALVAGE THERAPY; THROMBOCYTE;

BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIAC SURGICAL PROCEDURES; HEMODILUTION; HEMOGLOBINS; HUMANS;

EID: 0035005420     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Rock G, Akerblom O, Berseus O, et al. The supply of blood products in 10 different systems or countries. Transfus Sci 2000; 22: 171-82.
2. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60.
3. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17.
4. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 1998; 116: 460-7.
5. Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science 1980; 207: 541-3.
6. Struck E, De Vivie ER, Hehrlein F, et al. Multicentric quality assurance in cardiac surgery. QUADRA study of the German Society for Thoracic and Cardiovascular Surgery. (Quadra: quality data retrospective analysis). Thorac Cardiovasc Surg 1990; 38: 123-34.
7. Wallace EL, Churchill WH, Surgenor DM, Cho GS, McGurk S. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion 1998; 38: 625-36.
8. Dupuis JY, Bart B, Bryson G, Robblee J. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery. CMAJ 1999; 160: 997-1002.
9. Rubens FD, Dupuis JY, Robblee J, Rock G, Bryson GL, Wells PS. Feasibility of blinding in a randomized controlled trial comparing preoperative autologous blood donation and acute normovolemic hemodilution in adult cardiac surgery. Transfusion 2000; 40: 1058-62.
10. Love TR, Hendren WG, O'Keefe DD, Daggett WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987; 43: 508-12.
11. Commission of inquiry on the blood system in Canada. Final Report. Ottawa: Canadian Government Publishing - PWGCS 1997: 1046-73.
12. Thomas MJ, Gillon J, Desmond MJ. Consensus conference on autologous transfusion. Preoperative autologous donation. Transfusion 1996; 36: 633-9.
13. Popovsky MA, Whitaker B, Arnold NL Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995; 35: 734-7.
14. Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989; 262: 1963-8.
15. Kasper SM, Baumann M, Radbruch L, Harnischmacher U, Ohler JP, Buzello W. A pilot study of continuous ambulatory electrocardiography in patients donating blood for autologous use in elective coronary artery bypass grafting. Transfusion 1997; 37: 829-35.
16. Spiess BD, Sassetti R, McCarthy RJ, Narbone RF, Tuman KJ, Ivankovich AD. Autologous blood donation: hemodynamics in a high-risk patient population. Transfusion 1992; 32: 17-22.
17. Britton LW, Eastlund DT, Dziuban SW, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989; 47: 529-32.
18. Sandrelli L, Pardini A, Lorusso R, Sala ML, Licenziati M, Alfieri O. Impact of autologous blood predonation on a comprehensive blood conservation program. Ann Thorac Surg 1995; 59: 730-5.
19. Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998; 158: 610-6.
20. Tretiak R, Laupacis A, Riviere M, McKerracher K, Souetre E. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group. CMAJ 1996; 154: 1501-8.
21. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 719-24.
22. Cartier R, Brann S, Dagenais F, Martineau R, Couturier A. Systematic off-pump coronary artery revascularization in multivessel disease: experience of three hundred cases. J Thorac Cardiovasc Surg 2000; 119: 221-9.
23. Koutlas TC, Elbeery JR, Williams JM, Moran JF, Francalancia NA, Chitwood WR Jr. Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery. Ann Thorac Surg 2000; 69: 1042-7.
24. Kshettry VR, Flavin TF, Emery RW, Nicoloff DM, Arom KV, Petersen RJ. Does multivessel, off-pump coronary artery bypass reduce postoperative morbidity? Ann Thorac Surg 2000; 69: 1725-30.
25. Stamou SC, Pfister AJ, Dangas G, et al. Beating heart versus conventional single-vessel reoperative coronary artery bypass. Ann Thorac Surg 2000; 69: 1383-7.
26. Vural KM, Tasdemir O, Karagoz H, Emir M, Tarcan O, Bayazit K. Comparison of the early results of coronary artery bypass grafting with and without extracorporeal circulation. Thorac Cardiovasc Surg 1995; 43: 320-5.
27. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Economic outcome of off-pump coronary artery bypass surgery: a prospective randomized study. Ann Thorac Surg 1999; 68: 2237-42.
28. Dietrich W, Barankay A, Dilthey G, Mitto HP, Richter JA. Reduction of blood utilization during myocardial revascularization. J Thorac Cardiovasc Surg 1989; 97: 213-9.
29. Boldt J, Kling D, Weidler B, et al. Acute preoperative hemodilution in cardiac surgery: volume replacement with a hypertonic saline-hydroxyethyl starch solution. J Cardiothorac Vasc Anesth 1991; 5: 23-8.
30. Triulzi DJ, Ness PM. Intraoperative hemodilution and autologous platelet rich plasma collection: two techniques for collecting fresh autologous blood. Transfus Sci 1995; 16: 33-44.
31. Kochamba GS, Pfeffer TA, Sintek CF, Khonsari S. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996; 61: 900-3.
32. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998; 86: 9-15.
33. Rosengart TK, DeBois W, O'Hara M, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg 1998; 115: 426-38.
34. DeBois WJ, Sukhram, Y, McVey J, et al. Reduction in homologous blood transfusions using a low prime circuit. J Extracorp Technol 1996; 28: 58-62.
35. Cormack JE, Forest RJ, Groom RC, Morton J. Size makes a difference: use of a low-prime cardiopulmonary bypass circuit and autologous priming in small adults. Perfusion 2000; 15: 129-35.
36. Cromer MJ, Wolk DR. A minimal priming technique that allows for a higher circulating hemoglobin on cardiopulmonary bypass. Perfusion 1998; 13: 311-3.
37. Basu S, Marini CP, Bauman FG, et al. Comparative study of biological glues: cryoprecipitate glue, two-component fibrin sealant, and "French" glue. Ann Thorac Surg 1995; 60: 1255-62.
38. Berruyer M, Amiral J, Ffrench P, et al. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg 1993; 105: 892-7.
39. Anonymous. Report of the federal panel on formaldehyde. Environ Health Perspect 1982; 43: 139-68.
40. Bassiony AA, Shad SK, Rosin MD. Absence of GRF glue effect two years after aortic repair. Ann Thorac Surg 1999; 67: 1209.
41. Fukunaga S, Karck M, Harringer W, Cremer J, Rhein C, Haverich A. The use of gelatin-resorcin-formalin glue in acute aortic dissection type A. Eur J Cardiothorac Surg 1999; 15: 564-9.
42. Bachet J, Goudot B, Dreyfus GD, et al. Surgery for acute type A aortic dissection: the Hopital Foch experience (1977-1998). Ann Thorac Surg 1999; 67: 2006-9.
43. Awwad EE, Smith KR Jr. MRI of marked durai sac compression by surgicel in the immediately postoperative period after uncomplicated lumbar laminectomy. J Comput Assist Tomogr 1999; 23: 969-75.
44. Scher KS, Coil JA Jr. Effects of oxidized cellulose and microfibrillar collagen on infection. Surgery 1982; 91: 301-4.
45. Tanaka K, Takamoto S, Ohtsuka T, Kotsuka Y, Kawauchi M. Application of AdvaSeal for acute aortic dissection: experimental study. Ann Thorac Surg 1999; 68: 1308-12.
46. Rubens FD, Fergusson D, Wells PS, Huang M, McGowan JL, Laupacis A. Platelet-rich plasmapheresis in cardiac surgery: a meta-analysis of the effect on transfusion requirements. J Thorac Cardiovasc Surg 1998; 116: 641-7.
47. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
48. Shore-Lesserson L, Reich DL, DePerio M, Silvay G. Autologous platelet-rich plasmapheresis: risk versus benefit in repeat cardiac operations. Anesth Analg 1995; 81: 229-35.
49. Armellin G, Sorbara C, Bonato R, Pittarello D, Dal Cero P, Giron G. Intraoperative plasmapheresis in cardiac surgery. J Cardiothorac Vasc Anesth 1997; 11: 13-7.
50. Tobe CE, Vocelka C, Sepulvada R, et al. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study. J Thorac Cardiovasc Surg 1993; 105: 1007-13.
51. Ereth MH, Oliver WC Jr, Beynen FM, et al. Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery. Anesthesiology 1993; 79: 540-7.
52. Gutensohn K, Maerz M, Kuehnl P. Alteration of platelet-associated membrane glycoproteins during extracorporeal apheresis of peripheral blood progenitor cells. J Hematother 1997; 6: 315-21.
53. Despotis GJ, Joist JH, Hogue CW Jr, et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost 1996; 76: 902-8.
54. Despotis GJ, Joist JH, Hogue CW Jr, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995; 110: 46-54.
55. Gravlee GP, Haddon WS, Rothberger HK, et al. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg 1990; 99: 518-27.
56. Gravlee GP, Rogers AT, Dudas LM, et al. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology 1992; 76: 393-401.
57. Sakurada T, Kikuchi Y, Koushima R, Nakashima S, Hachiro Y, Kagaya H. [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system]. Nippon Kyobu Geka Gakkai Zasshi 1997; 45: 836-40.
58. Hardy JF, Belisle S, Robitaille D, Perrault J, Roy M, Gagnon L. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chrornogenic substrate for activated factor X. J Thorac Cardiovasc Surg 1996; 112: 154-61.
59. Tayama E, Hayashida N, Akasu K, et al. Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system. Artif Organs 2000; 24: 618-23.
60. Collart F, Caus T, Pomane C, et al. Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study. Artif Organs 2000; 24: 611-3.
61. Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation 1995; 92: 2579-84.
62. Mattox KL, Walker LE, Beall AC, Jordan GL. Blood availability for the trauma patient-autotransfusion. J Trauma 1975; 15: 663-9.
63. Martin J, Robitaille D, Perrault LP, et al. Reinfusion of mediastinal blood after heart surgery. J Thorac Cardiovasc Surg 2000; 120: 499-504.
64. Schulze HJ, Wendel HP, Khalighi K, Heller W, Seboldt H. The quality of autotransfused chest-drainage blood after cardiac surgery: a study of coagulation factors. Thorac Cardiovasc Surg 1996; 44: 183-7.
65. Huet C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999; 89: 861-9.
66. Body SC, Birmingham J, Parks R, et al. Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: a multicenter observational study. Multicenter Study of Perioperative Ischemia Research Group. J Cardiothorac Vasc Anesth 1999; 13: 410-6.
67. Dalrymple-Hay MJ, Pack L, Deakin CD, et al. Autotransfusion of washed shed mediastinal fluid decreases the requirement for autologous blood transfusion following cardiac surgery: a prospective randomized trial. Eur J Cardiothorac Surg 1999; 15: 830-4.
68. Zurick AM, Urzua J, Ghattas M, Cosgrove DM, Estafanous FG, Greenstreet R. Failure of positive end-expiratory pressure to decrease postoperative bleeding after cardiac surgery. Ann Thorac Surg 1982; 34: 608-11.
69. Murphy DA, Finlayson DC, Craver JM, et al. Effect of positive end-expiratory pressure on excessive mediastinal bleeding after cardiac operations. A controlled study. J Thorac Cardiovasc Surg 1983; 85: 864-9.